The pharmacological properties of anisodamine

Journal of Applied Toxicology

Volumn 27, Issue 2, 2007, Pages 116-121

  Poupko, Jay M ^a   Baskin, Steven I ^b   Moore, Eric ^c  

^a AMEDD Center and School   (United States)

^b US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

^c DEFENSE THREAT REDUCTION AGENCY   (United States)

Author keywords

Anisodamine; Cholinergic antagonist; Pharmacological properties; Therapeutic effects

Indexed keywords

ACETYLCHOLINE; ALCOHOL; ANISODAMINE; ATROPINE; ATROPINE DERIVATIVE; BELLADONNA ALKALOID; FREE RADICAL; INDOMETACIN; LIPOSOME; PHENYLEPHRINE; PILOCARPINE; SCOPOLAMINE; THROMBOXANE; TREMORINE;

ACUTE GLOMERULONEPHRITIS; ALPHA ADRENERGIC RECEPTOR BLOCKING; ANTICOAGULATION; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD FLOW; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; CELL DAMAGE; CELL MEMBRANE; CHINA; CHOLINERGIC RECEPTOR BLOCKING; COLIC; DRUG ANTAGONISM; DRUG DETERMINATION; DRUG HALF LIFE; DRUG INHIBITION; DRUG ISOLATION; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TISSUE LEVEL; ECLAMPSIA; FATTY ACID SYNTHESIS; HEART ARRHYTHMIA; HEART CONDUCTION; HUMAN; INTOXICATION; LUNG INSUFFICIENCY; MICROCIRCULATION; MIGRAINE; NEUROTOXICITY; NONHUMAN; OBSTRUCTIVE JAUNDICE; OPIATE ADDICTION; ORGANOPHOSPHORUS POISONING; PRIORITY JOURNAL; RADIATION PROTECTION; RESPIRATORY DISTRESS; RHEUMATOID ARTHRITIS; SEPTIC SHOCK; SNAKEBITE; STOMACH ULCER; UNSPECIFIED SIDE EFFECT; VASODILATATION;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; ANIMALS, LABORATORY; ATROPINE; DRUG EVALUATION, PRECLINICAL; DRUGS, CHINESE HERBAL; ORGANOPHOSPHORUS COMPOUNDS; PLANT EXTRACTS; POISONING; PULMONARY VALVE INSUFFICIENCY; SHOCK, SEPTIC; SOLANACEOUS ALKALOIDS; STOMACH ULCER;

EID: 33947581846     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1154     Document Type: Article

References (37)

1. Anonymous. 1975a. Anisodamine in treatment of some diseases with manifestations of acute microcirculatory insufficiency. Chin. Med. J. 1: 127-132.
2. Anonymous. 1975b. Pharmacologic effects of anisodamine. Chin. Med. J. 1: 133-138.
3. Chen JM, Gu SL. 1988. Anti-arrhythmic effects of anisodamine. Yao Xue Xue Bao 23: 857-859.
4. Department of Pharmacology, Institute of Materia Medica, Chinese Academy of Medical Sciences, et al. 1975. Pharmacologic effects of anisodamine. Chin. Med. J. 1: 133-138.
5. Esberg L, Ren J. 2004. The oxygen radical generator pyrogallol impairs cardiomyocyte contractile function via a superoxide and p38 MAP kinase-dependent pathway. Cardiovasc. Tox. 4: 375-384.
6. Fan GR, Hong ZY, Lin M, Yin XP, Wu YT. 2004. Study of stereoselective pharmacokinetics of anisodamine enantiomers in rabbits by capillary electrophoresis. J. Chromatogr. 809: 265-271.
7. Guo H-Y, Lorenz RR, Vanhoutte PM. 1992a. Anisodamine inhibits non-selectively muscarinic receptors in isolated canine veins. Chin. Med. J. 105: 5-10.
8. Guo H-Y, Lorenz RR, Vanhoutte PM. 1992b. Anisodamine inhibits acetylcholine-induced endothelium-dependent relaxation of canine femoral artery. Chin. Med. J. 105: 666-670.
9. Guo H-Y, Lorenz RR, Vanhoutte PM. 1993. Anisodamine at higher concentrations in inhibiting alpha-adrenergic responses in isolated canine blood vessels. Chin. Med. J. 106: 452-457.
10. Guo H-Y et al. 1992c. Anisodamine antagonizes acetylcholine- induced inhibition of adrenergic neurotransmission in the canine saphenous vein. Chin. Med. Sci. J. 7: 32-36.
11. Hwang F, Wang SM, Hu CC. 1983. The disordering effect of hyoscyamine drugs on phospholipids membranes. Biochim. Biophys. Acta 736: 220-225.
12. Kentala E et al. 1992. Intramuscular atropine in healthy volunteers: a pharmacokinetic and pharmacodynamic study. Int. J. Clin. Pharmacol. Ther. Toxicol. 28: 399-404.
13. Li QB et al. 1998. Anisodamine as an effective drug to treat snake bites. J. Natural Toxins 8: 327-330.
14. Luo ZY et al. 1992. Protective effect of anisodamine on cultured bovine pulmonary endothelial cell injury induced by oxygen-free radical. Arch. Surg. 127: 1204-1208.
15. Ma P, Wu C. 1992. Studies on the determination of plasma level and pharmacokinetic parameters of anisodamine by micellar liquid chromatography. Yao Xue Xue Bao 27: 763-767.
16. Pan SY et al. 2004. Comparison of the inhibitory efficacy of four belladonna drugs on gastrointestinal movement and cognitive function in food-deprived mice. Int. J. Exp. Clin. Pharm. 72: 177-183.
17. Pan S-Y et al. 2000. Learning deficits induced by four belladonna alkaloids are preferentially attenuated by tacrine. Acta Pharmacol. Sin. 21: 124-130.
18. 2+-ATPase from sarcoplasmic reticulum. Biosci. Biotechnol. Biochem. 68: 126-131.
19. Qiang Q et al. 2002. Protective effect of anisodamine on respiratory function after severe brain damage. Chin. J. Traumatol. 5: 352-354.
20. Ruan Q-R et al. 2001. Anisodamine counteracts lipopolysaccharide- induced tissue factor and plasminogen activator inhibitor-1 expression in human endothelial cells: contribution of the NF-kB pathway. J. Vasc. Res. 38: 13-19.
21. Ruan Q-R et al. 2002. Anisodamine inhibits endotoxin-induced tissue factor expression in human endothelial cells. J. Huazhong Univ. Sci. Technol. 22: 273-275.
22. Su J-J et al. 1984. Beneficial effect of anisodamine in hemorrhagic shock. Naunyn-Schmiedebergs Arch. Pharmacol. 325: 360-365.
23. Varma DR et al. 1986. Adrenoceptor blocking properties of atropine-like agents anisodamine and anosidine on brain and cardiovascular tissues of rats. Br. J. Pharmacol. 87: 587-594.
24. Wang H et al. 2003. Differentiating effects of anisodamine on cognitive amelioration and peripheral muscarinic side effects induced by pilocarpine in mice. Neurosci. Lett. 344: 173-176.
25. Xiao D et al. 1988. Inhibitory effects of anisodamine on endotoxin-induced prostaglandin production by cells in culture. Chin. Med. J. 101: 871-875.
26. Xie JX et al. 1975. The total synthesis of anisodamine. Chin. Sci. Bull. 20: 1977-198.
27. Xiu R-J et al. 1982. Anisodamine inhibits thromboxane synthesis, granulocyte aggregation and platelet aggregation. JAMA 247: 1458-1460.
28. Xiu R-J et al. 1980. Studies on microcirculation in the Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences. Microvasc. Res. 20: 371-373.
29. Yang P et al. 1991. Anti-arrhythmia and nervous system effects of anisodamine. Zhongguo Yao Li Xue Bao 12: 173-176.
30. Yao T et al. 1984. Effects of anisodamine on cardiovascular activities in endotoxin-shocked dogs. Chin. Med. J. 97: 871-876.
31. Ye S, Kyou M. 1988. Inhibitive effect of anisodamine on increase of vascular permeability after injection of Escherichia coli endotoxin. Zhhonguo Yixue Kexueyuan Xue Bao 10: 439-441.
32. Ying X, Ruan J. 2001. Effects of anisodamine on the detoxification of soman in rats. Chin. J. Pharmacol. Toxicol. 15: 302-305.
33. Yong DG et al. 1991. Anti-ulcer effect of anisodamine in rats. Zhongguo Yao Li Xue Bao 12: 522-525.
34. Zang S-P et al. 1987. Quantitative analysis of anisodamine-acetylcholine antagonism in canine tracheal smooth muscle Chin. Med. J. 100: 871-873.
35. Zhang JT et al. 2002. New drugs from medicinal plants. Therapie 57: 137-150.
36. Zhang H-M et al. 2001. Anisodamine inhibits shiga toxin type 2-mediated tumor necrosis factor-α production in vitro and in vivo. Exp. Biol. Med. 226: 597-604.
37. Zhu Y, Su J. 1986. Studies on antishock action of anisodamine: effect on liver lysosome stability. Zhongguo Binglishengli Zazh 4: 258-261.